Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
November 09, 2020 16:01 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the third quarter 2020. Please click here to review Harrow Health’s Letter to...
Harrow Health to Announce Third Quarter 2020 Financial Results on November 9, 2020
October 27, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, November 9, 2020, it will release third quarter 2020...
Harrow Health Appoints Larry Van Horn to its Board of Directors
September 30, 2020 08:00 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced the appointment of Larry Van Horn to its Board of Directors. Mark L. Baum, CEO of Harrow...
Harrow Health to Attend Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
September 11, 2020 11:22 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 4th Annual Best Ideas Growth (BIG4) Conference...
Harrow Health Publishes Second Quarter 2020 Letter to Stockholders
August 10, 2020 16:00 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2020. Please click here to review Harrow Health’s Letter to...
Harrow Health to Announce Second Quarter 2020 Financial Results on August 10, 2020
July 27, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, August 10, 2020, it will release second quarter 2020...
Leading Peer-Reviewed Journal Publishes Clinical Study on ImprimisRx’s Combination Prescription Eyedrops
July 13, 2020 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
Harrow Health Set to Join Russell 2000® Index and Russell 3000® Index
June 29, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., June 29, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it is set to join the small-cap Russell 2000® Index and the broad-market Russell 3000®...
ImprimisRx’s Patented Klarity-C® 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida’s 2,000 Optometrists
June 18, 2020 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
Harrow Health Publishes First Quarter 2020 Letter to Stockholders
May 11, 2020 16:01 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., May 11, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the first quarter 2020. Please click here to review Harrow Health’s Letter to...